From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma

In the Literature: May 2015

Anti-CD19 CAR T-Cells Show Promise in B-Cell Cancer
Lenvatinib Prolongs Progression-Free Survival in Advanced Thyroid Cancer
Ruxolitinib More Effective Than Standard Therapy in the Treatment of Polycythemia Vera

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

A Phase 3 Trial Comparing Axitinib and Sorafenib in Advanced Renal-Cell Cancer

Results 1 - 3 of 3

To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".

I'd like to receive:

TOP Print Edition

TOP Weekly e‑Newsletter

I have reviewed and consent to the terms of TOP's Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.